# Electrical Neuromodulation for Focal Epilepsy

> **NCT05844696** · PHASE1,PHASE2 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 65 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DEVICE:** Soterix MXN-5 HD-tES Model 5005A. Medtronic Percept DBS platform.

## Key facts

- **NCT ID:** NCT05844696
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05844696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05844696, "Electrical Neuromodulation for Focal Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05844696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*